Nutrition is more than just calories, carbohydrates and protein; it can be a powerful tool in managing lung disease and ...

Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

Chronic obstructive pulmonary disease (COPD) isn’t contagious. But people with COPD can transmit other infections when they cough. They may also have a greater risk of serious illness from a ...

By Sahil Pandey and Siddhi Mahatole Feb 23 (Reuters) - Gossamer Bio's experimental treatment failed to significantly improve ...

A European study finds hospitalisations and insufficient growth reduce health-related quality of life in childhood interstitial lung disease.

A new study shows how periodontitis, an oral disease, activates immune cells associated with aggravated progression of COPD. Severe gum disease has been linked to the progression of chronic ...